里程碑式试验或推动LSD获批用于治疗焦虑症

LSD could be approved for treating anxiety in the US as soon as 2027. This expectation comes after a landmark trial showed that a single dose of the psychedelic drug eased the mental health condition without severe or lasting side effects. “It’s a milestone,” says Greg Cooper at University College London, who wasn’t involved in the trial. “It looks fairly likely that approval from the [US Food and Drug Administration] will happen in the next year or two,” he says. “That would set a precedent for approval elsewhere, such as the UK and Europe.” The trial was made up of people with moderate or severe anxiety who had tried a range of standard therapies. …